HFA Premium Access

Elamipretide improves mitochondrial activity in the failing human heart.

Topic: Cell Signalling
Organised by Charité Medical School Berlin, supported by an unrestricted educational grant from Stealth Peptides

Presentation

About the speaker

Doctor Brian Stauffer

University of Colorado, Aurora (United States of America)
2 presentations
0 follower

3 more presentations in this session

Reaching the next level of drug development for heart failure: targetting mitochondria.

Speaker: Professor S. Anker (Berlin, DE)

Thumbnail

Elamipretide in heart failure with reduced ejection fraction.

Speaker: Professor H. Sabbah (Detroit, US)

Thumbnail

Clinical development concepts targeting mitochondria.

Speaker: Professor B. Pitt (Ann Arbor, US)

Thumbnail

Access the full session

Targeting mitochondria to improve outcomes in heart failure

Speakers: Doctor B. Stauffer, Professor S. Anker, Professor H. Sabbah, Professor B. Pitt
Thumbnail

About the event

Image

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk